No sign the pill blunts fitness in active women

Combined oral contraceptives are highly prevalent among premenopausal women, valued for their contraceptive efficacy and favourable safety profile. But for women who train, a persistent question hangs over them: does taking synthetic hormones change how the cardiovascular, respiratory or immune systems behave under exercise? The existing literature has been described as controversial and inconclusive, leaving active women and their coaches without a clear pooled answer. This review set out to compare cardiorespiratory and immune function between combined oral contraceptive users and non-users among women engaged in exercise.

The authors searched MEDLINE, CINAHL, Cochrane CENTRAL and other health databases via the EBSCOhost interface between January 2024 and May 2026. They included studies of healthy, physically active premenopausal women and female athletes aged 15-40, comparing combined oral contraceptive users with non-users, and appraised each with JBI tools. In total, 29 studies with 726 participants were included — 390 (53.7%) using combined oral contraceptives and 336 (46.3%) non-users. Nineteen studies with a comparator group entered the meta-analysis, and certainty of evidence was graded using the GRADE framework.

Across the pooled estimates, combined oral contraceptive use made little to no difference to the markers examined. Heart rate was essentially identical between groups (MD 0.02), respiratory parameters did not differ meaningfully (SMD -0.07), and IL-6, a marker of inflammation, showed no significant difference (MD -0.88). Body composition measured by BMI (MD -0.21) and broader metabolic changes (SMD -0.15) were likewise similar between users and non-users, with none of the comparisons reaching statistical significance. However, the certainty of evidence across all measured outcomes was rated low.

This pooling pushes back against the idea that the combined pill consistently impairs the physiology that matters for training, at least on these markers. But it does not settle the debate: the authors attribute the low certainty to small sample sizes, high risk of bias, varied methodological approaches and a lack of data from some geographical regions. They explicitly caution against extrapolating these findings for clinical decision-making. The open question is whether larger, better-designed studies in defined populations would confirm this pattern of no consistent difference.

If you are an active woman using or considering the combined pill, this is a reason to think it is not consistently dragging down heart rate, respiratory function, inflammation or body composition compared with non-users. It is equally a reason not to treat the matter as closed — the evidence base is small, methodologically uneven and rated low-certainty throughout. Contraceptive decisions involve far more than exercise physiology, and this review speaks only to the markers it measured. Treat it as one reassuring but provisional data point.